Compare KBR & CVSA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | KBR | CVSA |
|---|---|---|
| Founded | 1901 | 1987 |
| Country | United States | United States |
| Employees | N/A | 4996 |
| Industry | Military/Government/Technical | Other Consumer Services |
| Sector | Industrials | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.2B | 4.3B |
| IPO Year | 2006 | N/A |
| Metric | KBR | CVSA |
|---|---|---|
| Price | $37.08 | $115.97 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 8 | 2 |
| Target Price | $52.43 | ★ $150.00 |
| AVG Volume (30 Days) | ★ 1.7M | 364.4K |
| Earning Date | 05-05-2026 | 05-07-2026 |
| Dividend Yield | ★ 1.83% | N/A |
| EPS Growth | ★ 15.05 | N/A |
| EPS | ★ 0.80 | N/A |
| Revenue | ★ $5,767,000,000.00 | N/A |
| Revenue This Year | $4.56 | $9.66 |
| Revenue Next Year | $5.11 | $6.58 |
| P/E Ratio | $45.44 | ★ N/A |
| Revenue Growth | ★ 2.27 | N/A |
| 52 Week Low | $29.94 | $96.08 |
| 52 Week High | $52.23 | $135.96 |
| Indicator | KBR | CVSA |
|---|---|---|
| Relative Strength Index (RSI) | 61.77 | 41.09 |
| Support Level | $35.52 | $107.78 |
| Resistance Level | $38.48 | $119.02 |
| Average True Range (ATR) | 1.00 | 5.60 |
| MACD | 0.09 | -1.58 |
| Stochastic Oscillator | 82.61 | 23.27 |
KBR, formerly Kellogg Brown & Root, is a global provider of technology, integrated engineering, procurement, and construction delivery, and operations and maintenance services. The company's business is organized into two segments: mission technology solutions and sustainable technology solutions. KBR has operations in over 30 countries and employs approximately 36,000 people. The firm generated $7.8 billion in revenue in 2025.
Covista Inc is an American healthcare educator, serving more than 97,000 students and supported by a community of alumni across five accredited institutions. Through personalized, tech-enabled education powered by faculty and colleagues, it expands access to healthcare careers and addresses the U.S. healthcare workforce shortage at scale.